PMC Links for Books (Select 4859672) - PMC

Result Filters

Links from Books

Items: 3

Select item 56420481.

A Phase II Study of Cyclophosphamide, Etoposide, Vincristine and Prednisone (CEOP) Alternating with Pralatrexate (P) as Front Line Therapy for Patients with Peripheral T-Cell Lymphoma (PTCL): Final Results from the T- Cell Consortium Trial

Ranjana H. Advani, Stephen M. Ansell, Mary Jo Lechowicz, Anne W. Beaven, Fausto Loberiza, Kenneth R. Carson, Andrew M. Evens, Francine Foss, Steven Horwitz, Barbara Pro, Lauren Pinter Brown, Sonali M. Smith, Andrei R. Shustov, Kerry J. Savage, Julie Vose

Br J Haematol. Author manuscript; available in PMC 2017 Oct 16.

Published in final edited form as: Br J Haematol. 2016 Feb; 172(4): 535–544. Published online 2015 Dec 2. doi: 10.1111/bjh.13855

PMCID:: PMC5642048

Abstract Article PDF–623K

Select item 36273342.

Safety and efficacy of pralatrexate in the treatment of patients with relapsed or refractory peripheral T-cell lymphoma

Enrica Marchi, Owen A. O’Connor

Ther Adv Hematol. 2012 Aug; 3(4): 227–235. doi: 10.1177/2040620712445330

PMCID:: PMC3627334

Abstract Article PDF–2.7M

Select item 30838733.

Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study

Owen A. O'Connor, Barbara Pro, Lauren Pinter-Brown, Nancy Bartlett, Leslie Popplewell, Bertrand Coiffier, Mary Jo Lechowicz, Kerry J. Savage, Andrei R. Shustov, Christian Gisselbrecht, Eric Jacobsen, Pier Luigi Zinzani, Richard Furman, Andre Goy, Corinne Haioun, Michael Crump, Jasmine M. Zain, Eric Hsi, Adam Boyd, Steven Horwitz

J Clin Oncol. 2011 Mar 20; 29(9): 1182–1189. Published online 2011 Jan 18. doi: 10.1200/JCO.2010.29.9024